Review & Extract
Review what the system found in your sources. Approve only the findings you trust, edit anything that needs clinical context, and reject anything that does not belong.
Findings need review. The system surfaces possible assets, dosing, safety, monitoring, contraindications, and synergies from your sources. Approving a finding creates a source-backed record (asset, dosing reference, or evidence claim) — nothing is used until you approve it.
497
asset pending
3
dosing pending
0
safety pending
0
monitoring pending
0
contraindication pending
0
synergy pending
Reference lookup — Peptide Protocol Wiki
Pull a peptide’s reference profile from peptideprotocolwiki.com — stored as a source-attributed knowledge document, extracted into candidates, and used to fill the asset’s mechanism and a provider-review-required dosing reference. Secondary source; confirm before clinical use.
Find findings in a source
Recent source reviews
- Semax — Peptide Protocol Wiki referencecompleted · 28a/8d/10s/1m/1c/14syn · 2026-06-16
- TRZ — Peptide Protocol Wiki referencecompleted · 1a/6d/11s/1m/2c/0syn · 2026-06-16
- SNAP-8 — Peptide Protocol Wiki referencecompleted · 21a/0d/11s/1m/1c/17syn · 2026-06-16
- Sermorelin Acetate — Peptide Protocol Wiki referencecompleted · 17a/5d/13s/2m/2c/15syn · 2026-06-16
- RT3 — Peptide Protocol Wiki referencecompleted · 2a/19d/16s/1m/2c/1syn · 2026-06-16
- PT-141 — Peptide Protocol Wiki referencecompleted · 20a/4d/15s/1m/1c/10syn · 2026-06-16
- Oxytocin Acetate — Peptide Protocol Wiki referencecompleted · 6a/1d/10s/1m/1c/2syn · 2026-06-16
- NAD+ — Peptide Protocol Wiki referencecompleted · 27a/9d/11s/1m/1c/24syn · 2026-06-16
- Melanotan II (MT-2) — Peptide Protocol Wiki referencecompleted · 0a/0d/0s/0m/0c/0syn · 2026-06-16
- Melanotan I (MT-1) — Peptide Protocol Wiki referencecompleted · 7a/11d/21s/4m/1c/7syn · 2026-06-16
- Kisspeptin-10 — Peptide Protocol Wiki referencecompleted · 17a/1d/14s/0m/1c/4syn · 2026-06-16
- HCG — Peptide Protocol Wiki referencecompleted · 32a/12d/20s/1m/1c/3syn · 2026-06-16
- Glutathione — Peptide Protocol Wiki referencecompleted · 34a/19d/17s/5m/1c/39syn · 2026-06-16
- ARA-290 — Peptide Protocol Wiki referencecompleted · 14a/4d/9s/3m/1c/3syn · 2026-06-16
- VIP — Peptide Protocol Wiki referencecompleted · 26a/1d/11s/3m/1c/37syn · 2026-06-15
- Tesamorelin — Peptide Protocol Wiki referencecompleted · 22a/5d/14s/4m/1c/6syn · 2026-06-15
- TB-500 / TB4 — Peptide Protocol Wiki referencecompleted · 15a/4d/8s/3m/2c/7syn · 2026-06-15
- TA1 — Peptide Protocol Wiki referencecompleted · 26a/9d/14s/3m/3c/8syn · 2026-06-15
- SS-31 — Peptide Protocol Wiki referencecompleted · 26a/9d/9s/3m/1c/23syn · 2026-06-15
- Semax — Peptide Protocol Wiki referencecompleted · 26a/8d/10s/1m/1c/13syn · 2026-06-15
- Selank — Peptide Protocol Wiki referencecompleted · 34a/17d/11s/4m/1c/9syn · 2026-06-15
- MOTS-c — Peptide Protocol Wiki referencecompleted · 26a/3d/7s/0m/1c/9syn · 2026-06-15
- LL-37 — Peptide Protocol Wiki referencecompleted · 36a/23d/23s/5m/1c/13syn · 2026-06-15
- KPV — Peptide Protocol Wiki referencecompleted · 27a/1d/8s/2m/2c/17syn · 2026-06-15
- Ipamorelin — Peptide Protocol Wiki referencecompleted · 29a/13d/13s/4m/1c/10syn · 2026-06-15
- GHK-Cu — Peptide Protocol Wiki referencecompleted · 17a/1d/7s/1m/1c/10syn · 2026-06-15
- Epitalon — Peptide Protocol Wiki referencecompleted · 23a/1d/10s/2m/1c/5syn · 2026-06-15
- DSIP — Peptide Protocol Wiki referencecompleted · 17a/2d/10s/1m/1c/3syn · 2026-06-15
- CJC-1295 — Peptide Protocol Wiki referencecompleted · 21a/2d/13s/0m/1c/7syn · 2026-06-15
- BPC-157 — Peptide Protocol Wiki referencecompleted · 26a/8d/12s/1m/1c/7syn · 2026-06-15
- AOD-9604 — Peptide Protocol Wiki referencecompleted · 21a/3d/14s/0m/1c/7syn · 2026-06-15
- Integrative Peptide Therapy — Clinical Reference Protocol (Demo Import)completed · 9a/8d/2s/4m/4c/3syn · 2026-06-14
- Peptide Course - Cheat Sheet (Practice Better)completed · 0a/0d/0s/0m/0c/0syn · 2026-06-14
- Lyme Disease & Tick-Borne Co-infections: Backgroundcompleted · 0a/0d/0s/0m/0c/0syn · 2026-06-14
- EBV Reactivation: Backgroundcompleted · 0a/0d/0s/0m/0c/0syn · 2026-06-14
- LL-37 (Cathelicidin): Mechanistic Overviewcompleted · 1a/0d/0s/0m/0c/0syn · 2026-06-14